3
3
31
2JHP = 6.5, CHP); 6.99 (1H, d, J54 = 1.3, H-5); 7.08 (1H, d, J45 = 1.3, H-4); 7.41-7.95 (5H, m, Ph); P NMR
spectrum: 47.7. IR spectrum, ν, cm-1: 2630 (OH); 3120, 3095 (C–H of phenyl and imidazole ring); 2970, 2940,
2870 (C–H); 1580, 1490 (C=C, C=N of phenyl, imidazole ring); 1180 (P=O); 1045 (δC–O–H). Found, %: C 60.53;
H 7.11; N 10.07; P 11.30. C14H19N2O2P. Calculated, %: C 60.42; H 6.88; N 10.07; P 11.13.
2-[Ethyl(phenyl)phosphorylhydroxymethyl]-1-vinylimidazole (1g). Mixture of two diastereomers
1
(1.4:1). Yield 96%; mp 192-196°C (hexane). First diastereomer: H NMR spectrum (CDCl3/CD3OD), δ, ppm,
J (Hz): 1.03 (3H, dt, 3J = 7.6, 3JHP = 17.2 , CH3); 2.25 (2H, m, CH2); 4.78 (1H, dd, 2J = 1.7, 3J = 8.8, =CH2 cis);
2
3
2
3
5.28 (1H, dd, J = 1.7, J = 15.7, =CH2 trans); 5.53 (1H d, JHP = 5.8, CHP); 7.02 (1H, d, J = 1.4, H-5); 7.30
31
1
(1H, dd, =CH); 7.45-7.80 (6H m, H-4, Ph); P NMR spectrum: 48.4. Second diastereomer: H NMR spectrum,
3
3
2
3
δ, ppm, J (Hz): 0.99 (3H, dt, J = 7.6, JHP = 17.2, CH3); 2.10 (2H, m, CH2); 4.85 (1H, dd, J = 1.6, J = 8.8,
2
3
2
3
=CH2 cis); 5.32 (1H, dd, J = 1.6, J = 15.7, =CH2 trans); 5.42 (1H, d, JHP = 7.4, CHP); 6.96 (1H, d, J = 1.2,
H-5); 7.39 (1H, dd, =CH); 7.45-7.80 (6H, m, 4-H, Ph); 31P NMR spectrum: 48.1. IR spectrum, ν, cm-1: 2650
(OH); 3050, 3100 (CH2, C–H of phenyl and imidazole ring); 2965, 2870 (C–H); 1645 (C=C vinyl); 1590, 1490
(C=C, C=N of phenyl and imidazole ring); 1185 (P=O); 1045 (δC–O–H). Found, %: C 60.76; H 6,13; N 10.30;
P 11.74. C14H17N2O2P. Calculated, %: C 60.86; H 6.20; N 10.14; P 11.21.
2-(Diphenylphosphorylhydroxymethyl)-1-ethylbenzimidazole (1h). Yield 98%; mp 142-143°C
1
3
(hexane). H NMR spectrum, δ, ppm, J (Hz): 1.41 (3H, t, J = 7.2, CH3); 4.44 (2H, m CH2); 5.85 (1H, d,
3JHP = 6.6, CHP); 7.19-7.49 (10H, m, Ph); 7.68 (2H, m, Harom); 7.90 (2H, m, Harom). 31P NMR spectrum: 31.1.
IR spectrum, ν, cm-1: 3000 (OH); 3057 (C–H of phenyl, benzimidazole ring); 2936, 2861 (C–H); 1613, 1591,
1487 (C=C, C=N of phenyl, benzimidazole ring); 1202 (P=O); 1067 (δC–O–H). Found, %: C 70.56; H 5.73;
N 7.44; P 8.22. C22H21N2O2P. Calculated, %: C 70.20; H 5.62; N 7.44; P 8.23.
2-(Diphenylphosphorylhydroxymethyl)-1-vinylbenzimidazole (1i). Yield 97%; mp 178-180°C (hexane).
1H NMR spectrum, δ, ppm, J (Hz): 5.25 (1H, dd, 2J = 1.0, 3J = 8.8, =CH2 cis); 5.52 (1H, dd, 2J = 1.3, 3J = 15.6,
2
=CH2 trans); 5.84 (1H, d, JHP = 7.2, CHP); 7.25 (1H, dd, =CH); 7.36-7.63 (10 H, m, Ph); 7.90 (2H, m, Harom).
31P NMR spectrum: 31.3. IR spectrum, ν, cm-1: 3180 (OH); 3086, 3053 (CH2, CH, phenyl, benzimidazole ring);
1643 (C=C vinyl); 1607, 1590, 1518, 1457 (C=C, C=N phenyl, benzimidazole ring); 1190 (P=O); 1051 (δC–O–H).
Found, %: C 70.49; H 4.99; N 7.32; P 8.23. C22H19N2O2P. Calculated, %: C 70.58; H 5.12; N 7.48; P 8.27.
2-[Ethyl(phenyl)phosphorylhydroxymethyl-1-ethylbenzimidazole (1j). Mixture of two diastereomers
(2:1). Yield 96%; mp 129-132°C (hexane). First diastereomer: 1H NMR spectrum, δ, ppm, J (Hz): 1.09 (3H, dt,
3J = 7.7, JHP = 17.4, CH3CH2P); 1.35 (3H, t, J = 7.2, CH3CH2N); 2.35 (2H, m CH2P); 4.35 (2H, m, CH2N);
3
3
5.46 (1H, d, JHP = 7.0, CHP); 7.15-7.28 (9H, m, Ph, Harom); 31P NMR spectrum: 47.1. Second diastereomer:
2
1H NMR spectrum, δ, ppm, J (Hz): 0.98 (3H, dt, J = 7.9, JHP = 17.2, CH3CH2P); 1.33 (3H, t, J = 7.3,
3
3
3
2
CH3CH2N); 2.16 (2H, m CH2P); 4.28 (2H, m, CH2N); 5.41 (1H, d, JHP = 7.9, CHP); 7.15-7.28 (9H, m, Ph,
Harom). 31P NMR spectrum: 45.8. IR spectrum, ν, cm-1: 2700 (OH); 3070, 3010 (CH2, CH, phenyl, benzimidazole
ring); 2970, 2930 (C–H); 1605, 1480 (C=C, C=N phenyl, benzimidazole ring); 1190 (P=O); 1055 (δC–O–H).
Found, %: C 65.62; H 6.53; N 8.56; P 9.38. C18H21N2O2P. Calculated, %: C 65.84; H 6.45; N 8.53; P 9.43.
Synthesis of Sulfonate 3. Mixture of imidazole 1b (0.29 g, 0.9 mmol) and camphorsulfonic acid 2
(0.21 g, 0.9 mmol) in THF (6 ml) was stirred at room temperature for 0.5 h. The precipitate was filtered off,
washed with ether, and dried to give sulfonate 3 (0.49 g, 99%) as a mixture of diastereomers (ratio 1:1);
184-186°C (hexane), [α]
mp
D = 15.058° (c = 10, CH3OH). 1H NMR spectrum, δ, ppm, J (Hz): 0.79 (3H, s), 1.05
3
3
(3H, s) (2 CH3); 1.37 (t, J = 7.3), 1.37 (t, J = 7.3) (3H, CH3CH2 of 2 diastereomers); 1.35 (1H, m), 1.61 (1H,
3
m), 1.84 (1H, d, J = 18.2), 1.97 (1H, m), 2.02 (1H, m), 2.29 (1H, m), 2.58 (1H, m) (cyclohexane ring); 2.69
(1H, d, 2J = 14.7), 3.14 (1H, d) (CH2S); 4.42 (2H, m, CH2N); 6.52 (1H, d, 2JHP = 9.0, CHP); 7.01 (d, 3J54 = 1.9),
3
3
3
7.02 (d, J54 = 1.9) (1H, H-5 of two diastereomers); 7.28 (d, J45 = 1.9), 7.31 (d, 1H, J45 = 1.9) (H-4 of two
diastereomers); 7.44-7.94 (10H, m, Ph). IR spectrum, ν, cm-1: ~3000 (NH+); 1737 (C=O); 1590, 1520, 1470
(C=C, C=N of imidazole and phenyl rings); 1163, 1144 (νas S=O); 1040 (νs S=O); 1204 (P=O). Found, %: C 59.35;
H 6.53; N 4.81; P 5.57; S 5.53. C28H35N2O6PS. Calculated, %: C 60.20; H 6.32; N 5.01; P 5.54; S 5.74.
69